![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Suzhou No.4 Pharmaceutical Factory Suzhou Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Clindamycin hydrochloride, supported by a 'Withdrawn by EDQM Failure to CEP procedure' Certificate of Suitability (CEP) with the number R0-CEP 2005-287 - Rev 00
This Chemical Type CEP, issued on July 28, 2008, remains in force until December 20, 2013, ensuring its reliability within the pharmaceutical industry.
Substance Number 582 associated with this CEP further emphasizes